Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-24 @ 10:56 PM
NCT ID:
NCT06441669
Eligibility Criteria:
Inclusion Criteria:
* Patients are receiving a first unrelated cord blood transplantation (UCBT).
* Patients start letemovir prophylaxis within 0-28 days post UCBT.
Exclusion Criteria:
* Patients having active CMV DNAemia at the time of letermovir initiation.
* Patients recruited in a clinical study on an anti-CMV trial.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT06441669
Study Brief:
Protocol Section:
NCT06441669